alpha 2-Adrenergic receptors (alpha(2)ARs) present in the brainstem de
crease blood pressure and are targets for clinically effective antihyp
ertensive drugs. The existence of three alpha(2)AR subtypes, the lack
of subtype-specific ligands, and the cross-reactivity of alpha(2)AR ag
onists with imidazoline receptors has precluded an understanding of th
e role of individual alpha(2)AR subtypes in the hypotensive response.
Gene targeting was used to introduce a point mutation into the alpha 2
alpha AR subtype in the mouse genome. The hypotensive response to alp
ha(2)AR agonists was lost in the mutant mice, demonstrating that the a
lpha(2a)AR subtype plays a principal role in this response.